These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Causes of the decrease in cardiovascular mortality. Levy RI Am J Cardiol; 1984 Aug; 54(5):7C-13C. PubMed ID: 6475765 [TBL] [Abstract][Full Text] [Related]
4. Why are death rates from coronary heart disease decreasing? Which preventive measures are effective? Watkins LO Postgrad Med; 1984 Jun; 75(8):201-8, 211, 214. PubMed ID: 6610175 [TBL] [Abstract][Full Text] [Related]
5. Diet and the prevention of cardiovascular diseases. Paradis G; Fodor JG Can J Cardiol; 1999 Dec; 15 Suppl G():81G-8G. PubMed ID: 10692664 [No Abstract] [Full Text] [Related]
6. Multiple risk factor interventions for primary prevention of coronary heart disease. Ebrahim S; Davey Smith G Cochrane Database Syst Rev; 2000; (2):CD001561. PubMed ID: 10796813 [TBL] [Abstract][Full Text] [Related]
7. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734 [TBL] [Abstract][Full Text] [Related]
8. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H; Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421 [TBL] [Abstract][Full Text] [Related]
9. Mortality in the Stockholm heart disease secondary prevention study. Werkö L J Intern Med; 1989 Jun; 225(6):427-8. PubMed ID: 2664065 [No Abstract] [Full Text] [Related]
10. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. Yudkin JS BMJ; 1993 May; 306(6888):1313-8. PubMed ID: 8518573 [TBL] [Abstract][Full Text] [Related]
11. ["Under pressure" -- the clinical relevance of hypertension for the heart and circulation]. Lüscher TF Herz; 2006 Jun; 31(4):285-6. PubMed ID: 16810467 [No Abstract] [Full Text] [Related]
12. Primary and secondary prevention of cardiovascular disease in the elderly. García-Palmieri MR Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280 [TBL] [Abstract][Full Text] [Related]
13. The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review. Grimm RH Drugs; 1986; 31 Suppl 1():13-21. PubMed ID: 3720569 [TBL] [Abstract][Full Text] [Related]
14. Exercise in the reduction of cardiovascular events. Lessons from epidemiologic trials. Gibbons LW; Clark SM Cardiol Clin; 2001 Aug; 19(3):347-55. PubMed ID: 11570109 [TBL] [Abstract][Full Text] [Related]
15. Management of lipid disorders in the elderly. Playford DA; Watts GF Drugs Aging; 1997 Jun; 10(6):444-62. PubMed ID: 9205850 [TBL] [Abstract][Full Text] [Related]
16. Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension. Grimm RH; Hunninghake DB Am J Med; 1986 Feb; 80(2A):56-63. PubMed ID: 3946462 [TBL] [Abstract][Full Text] [Related]
17. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy. Isles CG; Paterson JR QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551 [TBL] [Abstract][Full Text] [Related]
18. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Cooper R; Cutler J; Desvigne-Nickens P; Fortmann SP; Friedman L; Havlik R; Hogelin G; Marler J; McGovern P; Morosco G; Mosca L; Pearson T; Stamler J; Stryer D; Thom T Circulation; 2000 Dec; 102(25):3137-47. PubMed ID: 11120707 [TBL] [Abstract][Full Text] [Related]